nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2C8—Simvastatin—atherosclerosis	0.0655	0.0972	CbGbCtD
Almotriptan—CYP2C8—Pravastatin—atherosclerosis	0.0641	0.0952	CbGbCtD
Almotriptan—CYP2C8—Lovastatin—atherosclerosis	0.0641	0.0952	CbGbCtD
Almotriptan—CYP2C19—Rosuvastatin—atherosclerosis	0.0591	0.0877	CbGbCtD
Almotriptan—CYP2C19—Simvastatin—atherosclerosis	0.0549	0.0816	CbGbCtD
Almotriptan—CYP2C19—Lovastatin—atherosclerosis	0.0537	0.0798	CbGbCtD
Almotriptan—CYP2D6—Niacin—atherosclerosis	0.0528	0.0785	CbGbCtD
Almotriptan—CYP2D6—Simvastatin—atherosclerosis	0.0417	0.062	CbGbCtD
Almotriptan—CYP2D6—Pravastatin—atherosclerosis	0.0409	0.0607	CbGbCtD
Almotriptan—CYP2D6—Lovastatin—atherosclerosis	0.0409	0.0607	CbGbCtD
Almotriptan—CYP3A4—Rosuvastatin—atherosclerosis	0.0286	0.0424	CbGbCtD
Almotriptan—CYP3A4—Ezetimibe—atherosclerosis	0.0286	0.0424	CbGbCtD
Almotriptan—CYP3A4—Simvastatin—atherosclerosis	0.0265	0.0394	CbGbCtD
Almotriptan—CYP3A4—Pravastatin—atherosclerosis	0.026	0.0386	CbGbCtD
Almotriptan—CYP3A4—Lovastatin—atherosclerosis	0.026	0.0386	CbGbCtD
Almotriptan—Neuropathy peripheral—Lovastatin—atherosclerosis	0.001	0.00446	CcSEcCtD
Almotriptan—Muscular weakness—Pravastatin—atherosclerosis	0.00099	0.00441	CcSEcCtD
Almotriptan—Melatonin—MPO—atherosclerosis	0.000985	0.571	CrCbGaD
Almotriptan—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.000983	0.00438	CcSEcCtD
Almotriptan—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00098	0.00436	CcSEcCtD
Almotriptan—Angina pectoris—Niacin—atherosclerosis	0.00096	0.00427	CcSEcCtD
Almotriptan—Sinusitis—Lovastatin—atherosclerosis	0.00096	0.00427	CcSEcCtD
Almotriptan—Mental disorder—Rosuvastatin—atherosclerosis	0.000949	0.00423	CcSEcCtD
Almotriptan—Bronchitis—Niacin—atherosclerosis	0.000948	0.00422	CcSEcCtD
Almotriptan—Angina pectoris—Pravastatin—atherosclerosis	0.000945	0.00421	CcSEcCtD
Almotriptan—Sweating increased—Pravastatin—atherosclerosis	0.000945	0.00421	CcSEcCtD
Almotriptan—Sinusitis—Ezetimibe—atherosclerosis	0.000941	0.00419	CcSEcCtD
Almotriptan—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000938	0.00418	CcSEcCtD
Almotriptan—Sinusitis—Simvastatin—atherosclerosis	0.000898	0.004	CcSEcCtD
Almotriptan—Pharyngitis—Ezetimibe—atherosclerosis	0.000894	0.00398	CcSEcCtD
Almotriptan—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000886	0.00394	CcSEcCtD
Almotriptan—Angioedema—Rosuvastatin—atherosclerosis	0.000862	0.00384	CcSEcCtD
Almotriptan—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000853	0.0038	CcSEcCtD
Almotriptan—Myocardial infarction—Pravastatin—atherosclerosis	0.000848	0.00378	CcSEcCtD
Almotriptan—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000848	0.00378	CcSEcCtD
Almotriptan—Chills—Lovastatin—atherosclerosis	0.000824	0.00367	CcSEcCtD
Almotriptan—Immune system disorder—Ezetimibe—atherosclerosis	0.000814	0.00362	CcSEcCtD
Almotriptan—Sinusitis—Pravastatin—atherosclerosis	0.000812	0.00361	CcSEcCtD
Almotriptan—Arthralgia—Rosuvastatin—atherosclerosis	0.000803	0.00358	CcSEcCtD
Almotriptan—Myalgia—Rosuvastatin—atherosclerosis	0.000803	0.00358	CcSEcCtD
Almotriptan—Rhinitis—Niacin—atherosclerosis	0.000791	0.00352	CcSEcCtD
Almotriptan—Mental disorder—Ezetimibe—atherosclerosis	0.000789	0.00351	CcSEcCtD
Almotriptan—Hypoaesthesia—Niacin—atherosclerosis	0.000785	0.00349	CcSEcCtD
Almotriptan—Erythema—Ezetimibe—atherosclerosis	0.000784	0.00349	CcSEcCtD
Almotriptan—Dysgeusia—Lovastatin—atherosclerosis	0.000783	0.00349	CcSEcCtD
Almotriptan—Rhinitis—Pravastatin—atherosclerosis	0.000779	0.00347	CcSEcCtD
Almotriptan—Confusional state—Rosuvastatin—atherosclerosis	0.000776	0.00346	CcSEcCtD
Almotriptan—Back pain—Lovastatin—atherosclerosis	0.000773	0.00344	CcSEcCtD
Almotriptan—Hypoaesthesia—Pravastatin—atherosclerosis	0.000773	0.00344	CcSEcCtD
Almotriptan—Pharyngitis—Pravastatin—atherosclerosis	0.000771	0.00343	CcSEcCtD
Almotriptan—Chills—Simvastatin—atherosclerosis	0.000771	0.00343	CcSEcCtD
Almotriptan—Visual impairment—Niacin—atherosclerosis	0.00076	0.00338	CcSEcCtD
Almotriptan—Back pain—Ezetimibe—atherosclerosis	0.000758	0.00338	CcSEcCtD
Almotriptan—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000755	0.00336	CcSEcCtD
Almotriptan—Vision blurred—Lovastatin—atherosclerosis	0.000753	0.00335	CcSEcCtD
Almotriptan—Mental disorder—Simvastatin—atherosclerosis	0.000753	0.00335	CcSEcCtD
Almotriptan—Tremor—Lovastatin—atherosclerosis	0.000749	0.00333	CcSEcCtD
Almotriptan—Visual impairment—Pravastatin—atherosclerosis	0.000748	0.00333	CcSEcCtD
Almotriptan—Erythema—Simvastatin—atherosclerosis	0.000748	0.00333	CcSEcCtD
Almotriptan—Ill-defined disorder—Lovastatin—atherosclerosis	0.000742	0.0033	CcSEcCtD
Almotriptan—Melatonin—ESR1—atherosclerosis	0.000739	0.429	CrCbGaD
Almotriptan—Eye disorder—Niacin—atherosclerosis	0.000737	0.00328	CcSEcCtD
Almotriptan—Tinnitus—Niacin—atherosclerosis	0.000735	0.00327	CcSEcCtD
Almotriptan—Dysgeusia—Simvastatin—atherosclerosis	0.000732	0.00326	CcSEcCtD
Almotriptan—Angioedema—Lovastatin—atherosclerosis	0.00073	0.00325	CcSEcCtD
Almotriptan—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000727	0.00324	CcSEcCtD
Almotriptan—Tinnitus—Pravastatin—atherosclerosis	0.000724	0.00322	CcSEcCtD
Almotriptan—Malaise—Lovastatin—atherosclerosis	0.000721	0.00321	CcSEcCtD
Almotriptan—Cardiac disorder—Pravastatin—atherosclerosis	0.000721	0.00321	CcSEcCtD
Almotriptan—Vertigo—Lovastatin—atherosclerosis	0.000718	0.0032	CcSEcCtD
Almotriptan—Angioedema—Ezetimibe—atherosclerosis	0.000716	0.00319	CcSEcCtD
Almotriptan—Chills—Niacin—atherosclerosis	0.000708	0.00315	CcSEcCtD
Almotriptan—Malaise—Ezetimibe—atherosclerosis	0.000707	0.00315	CcSEcCtD
Almotriptan—Vision blurred—Simvastatin—atherosclerosis	0.000705	0.00314	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000701	0.00312	CcSEcCtD
Almotriptan—Tremor—Simvastatin—atherosclerosis	0.000701	0.00312	CcSEcCtD
Almotriptan—Chills—Pravastatin—atherosclerosis	0.000697	0.0031	CcSEcCtD
Almotriptan—Insomnia—Rosuvastatin—atherosclerosis	0.000696	0.0031	CcSEcCtD
Almotriptan—Ill-defined disorder—Simvastatin—atherosclerosis	0.000694	0.00309	CcSEcCtD
Almotriptan—Palpitations—Ezetimibe—atherosclerosis	0.000693	0.00308	CcSEcCtD
Almotriptan—Paraesthesia—Rosuvastatin—atherosclerosis	0.000691	0.00308	CcSEcCtD
Almotriptan—Erythema—Niacin—atherosclerosis	0.000687	0.00306	CcSEcCtD
Almotriptan—Angioedema—Simvastatin—atherosclerosis	0.000683	0.00304	CcSEcCtD
Almotriptan—Myalgia—Lovastatin—atherosclerosis	0.000681	0.00303	CcSEcCtD
Almotriptan—Chest pain—Lovastatin—atherosclerosis	0.000681	0.00303	CcSEcCtD
Almotriptan—Arthralgia—Lovastatin—atherosclerosis	0.000681	0.00303	CcSEcCtD
Almotriptan—Anxiety—Lovastatin—atherosclerosis	0.000678	0.00302	CcSEcCtD
Almotriptan—Dyspepsia—Rosuvastatin—atherosclerosis	0.000678	0.00302	CcSEcCtD
Almotriptan—Hypertension—Ezetimibe—atherosclerosis	0.000677	0.00301	CcSEcCtD
Almotriptan—Malaise—Simvastatin—atherosclerosis	0.000674	0.003	CcSEcCtD
Almotriptan—Tension—Niacin—atherosclerosis	0.000674	0.003	CcSEcCtD
Almotriptan—Discomfort—Lovastatin—atherosclerosis	0.000672	0.00299	CcSEcCtD
Almotriptan—Vertigo—Simvastatin—atherosclerosis	0.000672	0.00299	CcSEcCtD
Almotriptan—Arthralgia—Ezetimibe—atherosclerosis	0.000668	0.00297	CcSEcCtD
Almotriptan—Chest pain—Ezetimibe—atherosclerosis	0.000668	0.00297	CcSEcCtD
Almotriptan—Myalgia—Ezetimibe—atherosclerosis	0.000668	0.00297	CcSEcCtD
Almotriptan—Nervousness—Niacin—atherosclerosis	0.000667	0.00297	CcSEcCtD
Almotriptan—Dry mouth—Lovastatin—atherosclerosis	0.000666	0.00296	CcSEcCtD
Almotriptan—Tension—Pravastatin—atherosclerosis	0.000663	0.00295	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000663	0.00295	CcSEcCtD
Almotriptan—Dysgeusia—Pravastatin—atherosclerosis	0.000662	0.00295	CcSEcCtD
Almotriptan—Discomfort—Ezetimibe—atherosclerosis	0.00066	0.00294	CcSEcCtD
Almotriptan—Pain—Rosuvastatin—atherosclerosis	0.000658	0.00293	CcSEcCtD
Almotriptan—Confusional state—Lovastatin—atherosclerosis	0.000658	0.00293	CcSEcCtD
Almotriptan—Nervousness—Pravastatin—atherosclerosis	0.000657	0.00292	CcSEcCtD
Almotriptan—Dry mouth—Ezetimibe—atherosclerosis	0.000653	0.00291	CcSEcCtD
Almotriptan—Anaphylactic shock—Lovastatin—atherosclerosis	0.000652	0.0029	CcSEcCtD
Almotriptan—Vision blurred—Niacin—atherosclerosis	0.000647	0.00288	CcSEcCtD
Almotriptan—Confusional state—Ezetimibe—atherosclerosis	0.000645	0.00287	CcSEcCtD
Almotriptan—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00064	0.00285	CcSEcCtD
Almotriptan—Vision blurred—Pravastatin—atherosclerosis	0.000637	0.00284	CcSEcCtD
Almotriptan—Arthralgia—Simvastatin—atherosclerosis	0.000637	0.00283	CcSEcCtD
Almotriptan—Chest pain—Simvastatin—atherosclerosis	0.000637	0.00283	CcSEcCtD
Almotriptan—Myalgia—Simvastatin—atherosclerosis	0.000637	0.00283	CcSEcCtD
Almotriptan—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000634	0.00282	CcSEcCtD
Almotriptan—Anxiety—Simvastatin—atherosclerosis	0.000634	0.00282	CcSEcCtD
Almotriptan—Tremor—Pravastatin—atherosclerosis	0.000633	0.00282	CcSEcCtD
Almotriptan—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00063	0.0028	CcSEcCtD
Almotriptan—Discomfort—Simvastatin—atherosclerosis	0.000629	0.0028	CcSEcCtD
Almotriptan—Nervous system disorder—Ezetimibe—atherosclerosis	0.000628	0.00279	CcSEcCtD
Almotriptan—Angioedema—Niacin—atherosclerosis	0.000627	0.00279	CcSEcCtD
Almotriptan—Ill-defined disorder—Pravastatin—atherosclerosis	0.000627	0.00279	CcSEcCtD
Almotriptan—Skin disorder—Ezetimibe—atherosclerosis	0.000622	0.00277	CcSEcCtD
Almotriptan—Angioedema—Pravastatin—atherosclerosis	0.000618	0.00275	CcSEcCtD
Almotriptan—Vertigo—Niacin—atherosclerosis	0.000617	0.00275	CcSEcCtD
Almotriptan—Syncope—Niacin—atherosclerosis	0.000616	0.00274	CcSEcCtD
Almotriptan—Confusional state—Simvastatin—atherosclerosis	0.000615	0.00274	CcSEcCtD
Almotriptan—Anaphylactic shock—Simvastatin—atherosclerosis	0.00061	0.00272	CcSEcCtD
Almotriptan—Malaise—Pravastatin—atherosclerosis	0.00061	0.00271	CcSEcCtD
Almotriptan—Abdominal pain—Rosuvastatin—atherosclerosis	0.000609	0.00271	CcSEcCtD
Almotriptan—Vertigo—Pravastatin—atherosclerosis	0.000607	0.0027	CcSEcCtD
Almotriptan—Palpitations—Niacin—atherosclerosis	0.000607	0.0027	CcSEcCtD
Almotriptan—Loss of consciousness—Niacin—atherosclerosis	0.000603	0.00269	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000594	0.00265	CcSEcCtD
Almotriptan—Insomnia—Lovastatin—atherosclerosis	0.00059	0.00263	CcSEcCtD
Almotriptan—Paraesthesia—Lovastatin—atherosclerosis	0.000586	0.00261	CcSEcCtD
Almotriptan—Myalgia—Niacin—atherosclerosis	0.000585	0.0026	CcSEcCtD
Almotriptan—Arthralgia—Niacin—atherosclerosis	0.000585	0.0026	CcSEcCtD
Almotriptan—Hypertension—Pravastatin—atherosclerosis	0.000584	0.0026	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000583	0.0026	CcSEcCtD
Almotriptan—Dyspnoea—Lovastatin—atherosclerosis	0.000582	0.00259	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00058	0.00258	CcSEcCtD
Almotriptan—Insomnia—Ezetimibe—atherosclerosis	0.000579	0.00258	CcSEcCtD
Almotriptan—Myalgia—Pravastatin—atherosclerosis	0.000576	0.00256	CcSEcCtD
Almotriptan—Arthralgia—Pravastatin—atherosclerosis	0.000576	0.00256	CcSEcCtD
Almotriptan—Chest pain—Pravastatin—atherosclerosis	0.000576	0.00256	CcSEcCtD
Almotriptan—Paraesthesia—Ezetimibe—atherosclerosis	0.000575	0.00256	CcSEcCtD
Almotriptan—Dyspepsia—Lovastatin—atherosclerosis	0.000574	0.00256	CcSEcCtD
Almotriptan—Anxiety—Pravastatin—atherosclerosis	0.000574	0.00255	CcSEcCtD
Almotriptan—Dry mouth—Niacin—atherosclerosis	0.000572	0.00255	CcSEcCtD
Almotriptan—Dyspnoea—Ezetimibe—atherosclerosis	0.00057	0.00254	CcSEcCtD
Almotriptan—Discomfort—Pravastatin—atherosclerosis	0.000569	0.00253	CcSEcCtD
Almotriptan—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000567	0.00253	CcSEcCtD
Almotriptan—Dyspepsia—Ezetimibe—atherosclerosis	0.000563	0.00251	CcSEcCtD
Almotriptan—Fatigue—Lovastatin—atherosclerosis	0.000562	0.0025	CcSEcCtD
Almotriptan—Anaphylactic shock—Niacin—atherosclerosis	0.00056	0.00249	CcSEcCtD
Almotriptan—Pain—Lovastatin—atherosclerosis	0.000558	0.00248	CcSEcCtD
Almotriptan—Confusional state—Pravastatin—atherosclerosis	0.000556	0.00248	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000556	0.00248	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000552	0.00246	CcSEcCtD
Almotriptan—Asthenia—Rosuvastatin—atherosclerosis	0.000552	0.00246	CcSEcCtD
Almotriptan—Insomnia—Simvastatin—atherosclerosis	0.000552	0.00246	CcSEcCtD
Almotriptan—Anaphylactic shock—Pravastatin—atherosclerosis	0.000552	0.00246	CcSEcCtD
Almotriptan—Fatigue—Ezetimibe—atherosclerosis	0.000552	0.00246	CcSEcCtD
Almotriptan—Shock—Niacin—atherosclerosis	0.000551	0.00245	CcSEcCtD
Almotriptan—Paraesthesia—Simvastatin—atherosclerosis	0.000548	0.00244	CcSEcCtD
Almotriptan—Pain—Ezetimibe—atherosclerosis	0.000547	0.00244	CcSEcCtD
Almotriptan—Tachycardia—Niacin—atherosclerosis	0.000547	0.00243	CcSEcCtD
Almotriptan—Pruritus—Rosuvastatin—atherosclerosis	0.000545	0.00242	CcSEcCtD
Almotriptan—Skin disorder—Niacin—atherosclerosis	0.000544	0.00242	CcSEcCtD
Almotriptan—Dyspnoea—Simvastatin—atherosclerosis	0.000544	0.00242	CcSEcCtD
Almotriptan—Hyperhidrosis—Niacin—atherosclerosis	0.000542	0.00241	CcSEcCtD
Almotriptan—Feeling abnormal—Lovastatin—atherosclerosis	0.000538	0.00239	CcSEcCtD
Almotriptan—Dyspepsia—Simvastatin—atherosclerosis	0.000537	0.00239	CcSEcCtD
Almotriptan—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000533	0.00238	CcSEcCtD
Almotriptan—Hyperhidrosis—Pravastatin—atherosclerosis	0.000533	0.00237	CcSEcCtD
Almotriptan—Feeling abnormal—Ezetimibe—atherosclerosis	0.000527	0.00235	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000527	0.00235	CcSEcCtD
Almotriptan—Diarrhoea—Rosuvastatin—atherosclerosis	0.000527	0.00235	CcSEcCtD
Almotriptan—Fatigue—Simvastatin—atherosclerosis	0.000526	0.00234	CcSEcCtD
Almotriptan—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000523	0.00233	CcSEcCtD
Almotriptan—Pain—Simvastatin—atherosclerosis	0.000522	0.00232	CcSEcCtD
Almotriptan—Body temperature increased—Lovastatin—atherosclerosis	0.000516	0.0023	CcSEcCtD
Almotriptan—Abdominal pain—Lovastatin—atherosclerosis	0.000516	0.0023	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000511	0.00227	CcSEcCtD
Almotriptan—Dizziness—Rosuvastatin—atherosclerosis	0.000509	0.00227	CcSEcCtD
Almotriptan—Insomnia—Niacin—atherosclerosis	0.000507	0.00226	CcSEcCtD
Almotriptan—Body temperature increased—Ezetimibe—atherosclerosis	0.000506	0.00225	CcSEcCtD
Almotriptan—Abdominal pain—Ezetimibe—atherosclerosis	0.000506	0.00225	CcSEcCtD
Almotriptan—Paraesthesia—Niacin—atherosclerosis	0.000503	0.00224	CcSEcCtD
Almotriptan—Feeling abnormal—Simvastatin—atherosclerosis	0.000503	0.00224	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000503	0.00224	CcSEcCtD
Almotriptan—Dyspnoea—Niacin—atherosclerosis	0.0005	0.00222	CcSEcCtD
Almotriptan—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000499	0.00222	CcSEcCtD
Almotriptan—Insomnia—Pravastatin—atherosclerosis	0.000499	0.00222	CcSEcCtD
Almotriptan—Somnolence—Niacin—atherosclerosis	0.000498	0.00222	CcSEcCtD
Almotriptan—Paraesthesia—Pravastatin—atherosclerosis	0.000495	0.00221	CcSEcCtD
Almotriptan—Dyspepsia—Niacin—atherosclerosis	0.000493	0.0022	CcSEcCtD
Almotriptan—Dyspnoea—Pravastatin—atherosclerosis	0.000492	0.00219	CcSEcCtD
Almotriptan—Dyspepsia—Pravastatin—atherosclerosis	0.000486	0.00216	CcSEcCtD
Almotriptan—Rash—Rosuvastatin—atherosclerosis	0.000485	0.00216	CcSEcCtD
Almotriptan—Dermatitis—Rosuvastatin—atherosclerosis	0.000485	0.00216	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Niacin—atherosclerosis	0.000484	0.00215	CcSEcCtD
Almotriptan—Abdominal pain—Simvastatin—atherosclerosis	0.000482	0.00215	CcSEcCtD
Almotriptan—Body temperature increased—Simvastatin—atherosclerosis	0.000482	0.00215	CcSEcCtD
Almotriptan—Headache—Rosuvastatin—atherosclerosis	0.000482	0.00215	CcSEcCtD
Almotriptan—Hypersensitivity—Lovastatin—atherosclerosis	0.000481	0.00214	CcSEcCtD
Almotriptan—Pain—Niacin—atherosclerosis	0.000479	0.00213	CcSEcCtD
Almotriptan—Fatigue—Pravastatin—atherosclerosis	0.000476	0.00212	CcSEcCtD
Almotriptan—Pain—Pravastatin—atherosclerosis	0.000472	0.0021	CcSEcCtD
Almotriptan—Hypersensitivity—Ezetimibe—atherosclerosis	0.000471	0.0021	CcSEcCtD
Almotriptan—Asthenia—Lovastatin—atherosclerosis	0.000468	0.00208	CcSEcCtD
Almotriptan—Pruritus—Lovastatin—atherosclerosis	0.000462	0.00206	CcSEcCtD
Almotriptan—Asthenia—Ezetimibe—atherosclerosis	0.000459	0.00204	CcSEcCtD
Almotriptan—Gastrointestinal pain—Niacin—atherosclerosis	0.000458	0.00204	CcSEcCtD
Almotriptan—Nausea—Rosuvastatin—atherosclerosis	0.000457	0.00204	CcSEcCtD
Almotriptan—Feeling abnormal—Pravastatin—atherosclerosis	0.000455	0.00202	CcSEcCtD
Almotriptan—Pruritus—Ezetimibe—atherosclerosis	0.000453	0.00202	CcSEcCtD
Almotriptan—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000451	0.00201	CcSEcCtD
Almotriptan—Hypersensitivity—Simvastatin—atherosclerosis	0.00045	0.002	CcSEcCtD
Almotriptan—Diarrhoea—Lovastatin—atherosclerosis	0.000446	0.00199	CcSEcCtD
Almotriptan—Abdominal pain—Niacin—atherosclerosis	0.000443	0.00197	CcSEcCtD
Almotriptan—Body temperature increased—Niacin—atherosclerosis	0.000443	0.00197	CcSEcCtD
Almotriptan—Asthenia—Simvastatin—atherosclerosis	0.000438	0.00195	CcSEcCtD
Almotriptan—Diarrhoea—Ezetimibe—atherosclerosis	0.000438	0.00195	CcSEcCtD
Almotriptan—Abdominal pain—Pravastatin—atherosclerosis	0.000436	0.00194	CcSEcCtD
Almotriptan—Body temperature increased—Pravastatin—atherosclerosis	0.000436	0.00194	CcSEcCtD
Almotriptan—Pruritus—Simvastatin—atherosclerosis	0.000432	0.00192	CcSEcCtD
Almotriptan—Dizziness—Lovastatin—atherosclerosis	0.000431	0.00192	CcSEcCtD
Almotriptan—Dizziness—Ezetimibe—atherosclerosis	0.000423	0.00188	CcSEcCtD
Almotriptan—Diarrhoea—Simvastatin—atherosclerosis	0.000418	0.00186	CcSEcCtD
Almotriptan—Vomiting—Lovastatin—atherosclerosis	0.000415	0.00185	CcSEcCtD
Almotriptan—Hypersensitivity—Niacin—atherosclerosis	0.000413	0.00184	CcSEcCtD
Almotriptan—Rash—Lovastatin—atherosclerosis	0.000411	0.00183	CcSEcCtD
Almotriptan—Dermatitis—Lovastatin—atherosclerosis	0.000411	0.00183	CcSEcCtD
Almotriptan—Headache—Lovastatin—atherosclerosis	0.000409	0.00182	CcSEcCtD
Almotriptan—Vomiting—Ezetimibe—atherosclerosis	0.000407	0.00181	CcSEcCtD
Almotriptan—Hypersensitivity—Pravastatin—atherosclerosis	0.000406	0.00181	CcSEcCtD
Almotriptan—Dizziness—Simvastatin—atherosclerosis	0.000404	0.0018	CcSEcCtD
Almotriptan—Rash—Ezetimibe—atherosclerosis	0.000403	0.0018	CcSEcCtD
Almotriptan—Dermatitis—Ezetimibe—atherosclerosis	0.000403	0.00179	CcSEcCtD
Almotriptan—Asthenia—Niacin—atherosclerosis	0.000402	0.00179	CcSEcCtD
Almotriptan—HTR1B—artery—atherosclerosis	0.000402	0.136	CbGeAlD
Almotriptan—Headache—Ezetimibe—atherosclerosis	0.000401	0.00178	CcSEcCtD
Almotriptan—Pruritus—Niacin—atherosclerosis	0.000396	0.00177	CcSEcCtD
Almotriptan—Asthenia—Pravastatin—atherosclerosis	0.000396	0.00176	CcSEcCtD
Almotriptan—Pruritus—Pravastatin—atherosclerosis	0.00039	0.00174	CcSEcCtD
Almotriptan—HTR1D—artery—atherosclerosis	0.000389	0.132	CbGeAlD
Almotriptan—Vomiting—Simvastatin—atherosclerosis	0.000388	0.00173	CcSEcCtD
Almotriptan—Nausea—Lovastatin—atherosclerosis	0.000388	0.00173	CcSEcCtD
Almotriptan—Rash—Simvastatin—atherosclerosis	0.000385	0.00171	CcSEcCtD
Almotriptan—Dermatitis—Simvastatin—atherosclerosis	0.000384	0.00171	CcSEcCtD
Almotriptan—Diarrhoea—Niacin—atherosclerosis	0.000383	0.00171	CcSEcCtD
Almotriptan—Headache—Simvastatin—atherosclerosis	0.000382	0.0017	CcSEcCtD
Almotriptan—Nausea—Ezetimibe—atherosclerosis	0.00038	0.00169	CcSEcCtD
Almotriptan—Diarrhoea—Pravastatin—atherosclerosis	0.000377	0.00168	CcSEcCtD
Almotriptan—Dizziness—Niacin—atherosclerosis	0.000371	0.00165	CcSEcCtD
Almotriptan—Dizziness—Pravastatin—atherosclerosis	0.000365	0.00162	CcSEcCtD
Almotriptan—Nausea—Simvastatin—atherosclerosis	0.000362	0.00161	CcSEcCtD
Almotriptan—Vomiting—Niacin—atherosclerosis	0.000356	0.00159	CcSEcCtD
Almotriptan—Rash—Niacin—atherosclerosis	0.000353	0.00157	CcSEcCtD
Almotriptan—Dermatitis—Niacin—atherosclerosis	0.000353	0.00157	CcSEcCtD
Almotriptan—Headache—Niacin—atherosclerosis	0.000351	0.00156	CcSEcCtD
Almotriptan—Vomiting—Pravastatin—atherosclerosis	0.000351	0.00156	CcSEcCtD
Almotriptan—Rash—Pravastatin—atherosclerosis	0.000348	0.00155	CcSEcCtD
Almotriptan—Dermatitis—Pravastatin—atherosclerosis	0.000348	0.00155	CcSEcCtD
Almotriptan—Headache—Pravastatin—atherosclerosis	0.000346	0.00154	CcSEcCtD
Almotriptan—Nausea—Niacin—atherosclerosis	0.000333	0.00148	CcSEcCtD
Almotriptan—Nausea—Pravastatin—atherosclerosis	0.000328	0.00146	CcSEcCtD
Almotriptan—HTR1B—blood vessel—atherosclerosis	0.000313	0.106	CbGeAlD
Almotriptan—HTR1D—blood vessel—atherosclerosis	0.000303	0.103	CbGeAlD
Almotriptan—FMO3—adipose tissue—atherosclerosis	0.00021	0.0712	CbGeAlD
Almotriptan—HTR1D—connective tissue—atherosclerosis	0.000155	0.0527	CbGeAlD
Almotriptan—FMO3—liver—atherosclerosis	0.000147	0.0499	CbGeAlD
Almotriptan—HTR1B—cardiovascular system—atherosclerosis	0.00014	0.0474	CbGeAlD
Almotriptan—HTR1D—cardiovascular system—atherosclerosis	0.000135	0.0459	CbGeAlD
Almotriptan—MAOA—connective tissue—atherosclerosis	0.000118	0.0402	CbGeAlD
Almotriptan—MAOA—cardiovascular system—atherosclerosis	0.000103	0.0349	CbGeAlD
Almotriptan—MAOA—adipose tissue—atherosclerosis	9.07e-05	0.0308	CbGeAlD
Almotriptan—CYP2E1—cardiovascular system—atherosclerosis	7.72e-05	0.0262	CbGeAlD
Almotriptan—CYP2C19—liver—atherosclerosis	6.5e-05	0.0221	CbGeAlD
Almotriptan—MAOA—liver—atherosclerosis	6.36e-05	0.0216	CbGeAlD
Almotriptan—CYP2C8—liver—atherosclerosis	5.67e-05	0.0193	CbGeAlD
Almotriptan—CYP1A2—liver—atherosclerosis	5.31e-05	0.018	CbGeAlD
Almotriptan—CYP2E1—liver—atherosclerosis	4.78e-05	0.0162	CbGeAlD
Almotriptan—CYP3A4—liver—atherosclerosis	3.84e-05	0.013	CbGeAlD
Almotriptan—CYP2D6—liver—atherosclerosis	3.78e-05	0.0128	CbGeAlD
Almotriptan—HTR1D—Signaling Pathways—APOE—atherosclerosis	1.72e-05	0.000176	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AGT—atherosclerosis	1.71e-05	0.000176	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOA2—atherosclerosis	1.71e-05	0.000176	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.71e-05	0.000176	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.71e-05	0.000176	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.71e-05	0.000176	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CAV1—atherosclerosis	1.7e-05	0.000174	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APOA1—atherosclerosis	1.7e-05	0.000174	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.69e-05	0.000173	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.69e-05	0.000173	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—LEP—atherosclerosis	1.68e-05	0.000172	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOE—atherosclerosis	1.68e-05	0.000172	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.68e-05	0.000172	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.68e-05	0.000172	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NAMPT—atherosclerosis	1.68e-05	0.000172	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.67e-05	0.000171	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—LIPC—atherosclerosis	1.67e-05	0.000171	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CAV1—atherosclerosis	1.66e-05	0.000171	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.66e-05	0.000171	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOA1—atherosclerosis	1.66e-05	0.00017	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOC3—atherosclerosis	1.66e-05	0.00017	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—LDLR—atherosclerosis	1.65e-05	0.000169	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ESR1—atherosclerosis	1.64e-05	0.000168	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LPA—atherosclerosis	1.63e-05	0.000168	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMGCR—atherosclerosis	1.63e-05	0.000167	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CG—atherosclerosis	1.62e-05	0.000167	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—F2—atherosclerosis	1.62e-05	0.000166	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CETP—atherosclerosis	1.61e-05	0.000165	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ESR1—atherosclerosis	1.6e-05	0.000164	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—F2—atherosclerosis	1.58e-05	0.000162	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—BGN—atherosclerosis	1.58e-05	0.000162	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.57e-05	0.000161	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PPARG—atherosclerosis	1.57e-05	0.000161	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOA5—atherosclerosis	1.57e-05	0.000161	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—FABP4—atherosclerosis	1.56e-05	0.00016	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LCAT—atherosclerosis	1.56e-05	0.00016	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CG—atherosclerosis	1.55e-05	0.000159	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.54e-05	0.000158	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SCARB1—atherosclerosis	1.54e-05	0.000158	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—INS—atherosclerosis	1.54e-05	0.000158	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOA4—atherosclerosis	1.54e-05	0.000157	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—LIPC—atherosclerosis	1.53e-05	0.000157	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOC3—atherosclerosis	1.52e-05	0.000156	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.52e-05	0.000156	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CG—atherosclerosis	1.52e-05	0.000155	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—LDLR—atherosclerosis	1.51e-05	0.000155	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.51e-05	0.000155	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.51e-05	0.000155	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.5e-05	0.000154	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.49e-05	0.000153	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK3—atherosclerosis	1.48e-05	0.000152	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CETP—atherosclerosis	1.48e-05	0.000152	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.48e-05	0.000151	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.47e-05	0.000151	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.47e-05	0.000151	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—INS—atherosclerosis	1.47e-05	0.00015	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.46e-05	0.000149	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMGCR—atherosclerosis	1.45e-05	0.000149	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK3—atherosclerosis	1.45e-05	0.000149	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.45e-05	0.000149	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL2—atherosclerosis	1.44e-05	0.000148	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HMOX1—atherosclerosis	1.44e-05	0.000148	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—INS—atherosclerosis	1.44e-05	0.000147	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IGF1—atherosclerosis	1.42e-05	0.000145	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.42e-05	0.000145	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL2—atherosclerosis	1.41e-05	0.000145	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALB—atherosclerosis	1.41e-05	0.000145	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.39e-05	0.000143	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IGF1—atherosclerosis	1.39e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOB—atherosclerosis	1.38e-05	0.000141	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NOS3—atherosclerosis	1.35e-05	0.000138	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SERPINE1—atherosclerosis	1.35e-05	0.000138	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.35e-05	0.000138	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—atherosclerosis	1.34e-05	0.000138	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.34e-05	0.000137	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.32e-05	0.000136	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.32e-05	0.000136	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.32e-05	0.000136	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOA2—atherosclerosis	1.32e-05	0.000136	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SERPINE1—atherosclerosis	1.32e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—LPL—atherosclerosis	1.32e-05	0.000135	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.31e-05	0.000134	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.31e-05	0.000134	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.31e-05	0.000134	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.3e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LIPC—atherosclerosis	1.3e-05	0.000133	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—atherosclerosis	1.3e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCA1—atherosclerosis	1.3e-05	0.000133	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOC3—atherosclerosis	1.29e-05	0.000132	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GPX1—atherosclerosis	1.29e-05	0.000132	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOS3—atherosclerosis	1.29e-05	0.000132	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LDLR—atherosclerosis	1.28e-05	0.000131	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LPA—atherosclerosis	1.26e-05	0.000129	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOS3—atherosclerosis	1.26e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CETP—atherosclerosis	1.25e-05	0.000128	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CD36—atherosclerosis	1.25e-05	0.000128	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.25e-05	0.000128	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—atherosclerosis	1.23e-05	0.000126	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—BGN—atherosclerosis	1.22e-05	0.000125	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOA5—atherosclerosis	1.21e-05	0.000124	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.2e-05	0.000123	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOB—atherosclerosis	1.19e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.19e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—atherosclerosis	1.19e-05	0.000122	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.17e-05	0.00012	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARA—atherosclerosis	1.16e-05	0.000119	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.16e-05	0.000119	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.16e-05	0.000119	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL8—atherosclerosis	1.14e-05	0.000117	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—LPL—atherosclerosis	1.14e-05	0.000117	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.13e-05	0.000116	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AGT—atherosclerosis	1.13e-05	0.000116	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.12e-05	0.000115	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL8—atherosclerosis	1.12e-05	0.000114	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.11e-05	0.000114	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GPX1—atherosclerosis	1.11e-05	0.000114	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOE—atherosclerosis	1.1e-05	0.000113	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—atherosclerosis	1.1e-05	0.000113	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CAV1—atherosclerosis	1.09e-05	0.000112	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOA1—atherosclerosis	1.09e-05	0.000112	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—atherosclerosis	1.08e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CD36—atherosclerosis	1.08e-05	0.000111	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—atherosclerosis	1.08e-05	0.000111	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOB—atherosclerosis	1.06e-05	0.000109	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—atherosclerosis	1.06e-05	0.000109	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.04e-05	0.000106	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—atherosclerosis	1.03e-05	0.000106	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—atherosclerosis	1.03e-05	0.000105	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.02e-05	0.000105	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.02e-05	0.000105	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NFKB1—atherosclerosis	1.02e-05	0.000105	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—LPL—atherosclerosis	1.02e-05	0.000104	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—atherosclerosis	1.01e-05	0.000104	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.01e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.01e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARA—atherosclerosis	1.01e-05	0.000103	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK8—atherosclerosis	1e-05	0.000103	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LIPC—atherosclerosis	1e-05	0.000103	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—atherosclerosis	1e-05	0.000103	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NFKB1—atherosclerosis	9.99e-06	0.000102	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CG—atherosclerosis	9.97e-06	0.000102	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOC3—atherosclerosis	9.96e-06	0.000102	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GPX1—atherosclerosis	9.92e-06	0.000102	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LDLR—atherosclerosis	9.9e-06	0.000101	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK8—atherosclerosis	9.82e-06	0.000101	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—atherosclerosis	9.79e-06	0.0001	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOB—atherosclerosis	9.79e-06	0.0001	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AGT—atherosclerosis	9.75e-06	9.99e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CETP—atherosclerosis	9.67e-06	9.91e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CD36—atherosclerosis	9.66e-06	9.9e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARG—atherosclerosis	9.62e-06	9.86e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOE—atherosclerosis	9.55e-06	9.79e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—atherosclerosis	9.53e-06	9.77e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAV1—atherosclerosis	9.46e-06	9.7e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOA1—atherosclerosis	9.44e-06	9.68e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—INS—atherosclerosis	9.44e-06	9.67e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—LPL—atherosclerosis	9.35e-06	9.59e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—atherosclerosis	9.26e-06	9.49e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.26e-06	9.49e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—atherosclerosis	9.17e-06	9.4e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—atherosclerosis	9.15e-06	9.38e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GPX1—atherosclerosis	9.12e-06	9.35e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—atherosclerosis	9.07e-06	9.3e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARA—atherosclerosis	8.98e-06	9.21e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—atherosclerosis	8.98e-06	9.2e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CD36—atherosclerosis	8.89e-06	9.11e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK3—atherosclerosis	8.76e-06	8.98e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.74e-06	8.96e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AGT—atherosclerosis	8.7e-06	8.92e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—atherosclerosis	8.66e-06	8.88e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—atherosclerosis	8.65e-06	8.87e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CG—atherosclerosis	8.62e-06	8.83e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK3—atherosclerosis	8.58e-06	8.79e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOE—atherosclerosis	8.52e-06	8.74e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—atherosclerosis	8.5e-06	8.71e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAV1—atherosclerosis	8.44e-06	8.66e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOA1—atherosclerosis	8.43e-06	8.64e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—atherosclerosis	8.42e-06	8.63e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—atherosclerosis	8.32e-06	8.53e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARG—atherosclerosis	8.32e-06	8.53e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOB—atherosclerosis	8.3e-06	8.51e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—atherosclerosis	8.28e-06	8.48e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARA—atherosclerosis	8.26e-06	8.47e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—INS—atherosclerosis	8.16e-06	8.36e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—atherosclerosis	8.07e-06	8.27e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AGT—atherosclerosis	8e-06	8.2e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LPL—atherosclerosis	7.92e-06	8.12e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOE—atherosclerosis	7.84e-06	8.04e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.79e-06	7.99e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAV1—atherosclerosis	7.77e-06	7.96e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOA1—atherosclerosis	7.75e-06	7.94e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPX1—atherosclerosis	7.73e-06	7.92e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CG—atherosclerosis	7.69e-06	7.88e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—atherosclerosis	7.57e-06	7.76e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CD36—atherosclerosis	7.53e-06	7.72e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—atherosclerosis	7.48e-06	7.67e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARG—atherosclerosis	7.42e-06	7.61e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—INS—atherosclerosis	7.28e-06	7.46e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—atherosclerosis	7.15e-06	7.33e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—atherosclerosis	7.13e-06	7.31e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.07e-06	7.25e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARA—atherosclerosis	7e-06	7.17e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARG—atherosclerosis	6.83e-06	7e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AGT—atherosclerosis	6.78e-06	6.95e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—INS—atherosclerosis	6.7e-06	6.86e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.69e-06	6.85e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—atherosclerosis	6.68e-06	6.84e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOE—atherosclerosis	6.64e-06	6.81e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAV1—atherosclerosis	6.58e-06	6.74e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOA1—atherosclerosis	6.56e-06	6.73e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—atherosclerosis	6.54e-06	6.71e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—atherosclerosis	6.4e-06	6.57e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOB—atherosclerosis	6.4e-06	6.56e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—atherosclerosis	6.39e-06	6.55e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—atherosclerosis	6.27e-06	6.43e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.23e-06	6.39e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—atherosclerosis	6.2e-06	6.36e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—atherosclerosis	6.14e-06	6.29e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LPL—atherosclerosis	6.11e-06	6.27e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.99e-06	6.14e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPX1—atherosclerosis	5.97e-06	6.11e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—atherosclerosis	5.91e-06	6.06e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—atherosclerosis	5.87e-06	6.02e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—atherosclerosis	5.84e-06	5.99e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CD36—atherosclerosis	5.81e-06	5.96e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—atherosclerosis	5.79e-06	5.93e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARG—atherosclerosis	5.78e-06	5.93e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—INS—atherosclerosis	5.67e-06	5.82e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.51e-06	5.64e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARA—atherosclerosis	5.4e-06	5.54e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.37e-06	5.51e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AGT—atherosclerosis	5.23e-06	5.36e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—atherosclerosis	5.2e-06	5.33e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOE—atherosclerosis	5.13e-06	5.25e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAV1—atherosclerosis	5.08e-06	5.21e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOA1—atherosclerosis	5.07e-06	5.19e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—atherosclerosis	4.98e-06	5.1e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.63e-06	4.74e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.55e-06	4.66e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARG—atherosclerosis	4.46e-06	4.58e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—INS—atherosclerosis	4.38e-06	4.49e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—atherosclerosis	4.01e-06	4.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—atherosclerosis	3.84e-06	3.94e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—atherosclerosis	3.8e-06	3.9e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.51e-06	3.6e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—atherosclerosis	3.29e-06	3.37e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—atherosclerosis	2.94e-06	3.01e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—atherosclerosis	2.7e-06	2.77e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—atherosclerosis	2.29e-06	2.34e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—atherosclerosis	1.76e-06	1.81e-05	CbGpPWpGaD
